Novel MALT1 Mutation Linked to Immunodeficiency, Immune Dysregulation, and an Abnormal T Cell Receptor Repertoire

[1]  Andrew J. Oler,et al.  Hypomorphic caspase activation and recruitment domain 11 (CARD11) mutations associated with diverse immunologic phenotypes with or without atopic disease , 2019, The Journal of allergy and clinical immunology.

[2]  J. Milner,et al.  The CBM-opathies—A Rapidly Expanding Spectrum of Human Inborn Errors of Immunity Caused by Mutations in the CARD11-BCL10-MALT1 Complex , 2018, Front. Immunol..

[3]  M. Thome,et al.  Holding All the CARDs: How MALT1 Controls CARMA/CARD-Dependent Signaling , 2018, Front. Immunol..

[4]  W. Grody,et al.  The Value of T-Cell Receptor γ (TRG) Clonality Evaluation by Next-Generation Sequencing in Clinical Hematolymphoid Tissues , 2018, American Journal of Clinical Pathology.

[5]  J. Jameson,et al.  Human αβ and γδ T Cells in Skin Immunity and Disease , 2018, Front. Immunol..

[6]  S. Kamel‐Reid,et al.  T cell clonality assessment: past, present and future , 2017, Journal of Clinical Pathology.

[7]  D. Merico,et al.  Combined immunodeficiency and atopy caused by a dominant negative mutation in caspase activation and recruitment domain family member 11 (CARD11) , 2017, The Journal of allergy and clinical immunology.

[8]  J. McElwee,et al.  Germline hypomorphic CARD11 mutations in severe atopic disease , 2017, Nature Genetics.

[9]  K. Schwarz,et al.  A prospective study on the natural history of patients with profound combined immunodeficiency: An interim analysis , 2017, The Journal of allergy and clinical immunology.

[10]  F. Rieux-Laucat,et al.  Deficiency in Mucosa-associated Lymphoid Tissue Lymphoma Translocation 1: A Novel Cause of IPEX-Like Syndrome , 2017, Journal of pediatric gastroenterology and nutrition.

[11]  Hao Wu,et al.  Characterization of T and B cell repertoire diversity in patients with RAG deficiency , 2016, Science Immunology.

[12]  M. Thome,et al.  Role of the CARMA1/BCL10/MALT1 complex in lymphoid malignancies , 2016, Current opinion in hematology.

[13]  M. van der Burg,et al.  Combined immunodeficiencies: twenty years experience from a single center in Turkey , 2016, Central-European journal of immunology.

[14]  R. P. Diego.  Immunodeficiency and CARD-BCL10-MALT1 , 2015 .

[15]  H. Abel,et al.  T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides. , 2015, Journal of the American Academy of Dermatology.

[16]  J. Bertin,et al.  MALT1 Protease Activity Is Required for Innate and Adaptive Immune Responses , 2015, PloS one.

[17]  T. Mak,et al.  Deficiency of MALT1 Paracaspase Activity Results in Unbalanced Regulatory and Effector T and B Cell Responses Leading to Multiorgan Inflammation , 2015, The Journal of Immunology.

[18]  L. Notarangelo,et al.  Timely and spatially regulated maturation of B and T cell repertoire during human fetal development , 2015, Science Translational Medicine.

[19]  R. Srinivasan,et al.  Combined Immunodeficiency Due to MALT1 Mutations, Treated by Hematopoietic Cell Transplantation , 2015, Journal of Clinical Immunology.

[20]  M. Kriegsmann,et al.  Uncoupling Malt1 threshold function from paracaspase activity results in destructive autoimmune inflammation. , 2014, Cell reports.

[21]  L. Kane,et al.  T Cell Receptor–Dependent Activation of mTOR Signaling in T Cells Is Mediated by Carma1 and MALT1, But Not Bcl10 , 2014, Science Signaling.

[22]  R. Holt,et al.  Combined immunodeficiency associated with homozygous MALT1 mutations. , 2014, The Journal of allergy and clinical immunology.

[23]  J. Casanova,et al.  Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015 , 2015, Journal of Clinical Immunology.

[24]  Toshiro K. Ohsumi,et al.  A homozygous mucosa-associated lymphoid tissue 1 (MALT1) mutation in a family with combined immunodeficiency. , 2013, The Journal of allergy and clinical immunology.

[25]  I. Dalal,et al.  The Application of Clinical Genetics the Genetic Basis of Severe Combined Immunodeficiency and Its Variants , 2022 .

[26]  A. Nahum,et al.  Immune deficiencies , infection , and systemic immune disorders Defining combined immunodeficiency , 2012 .

[27]  Johnny S. H. Kwan,et al.  A comprehensive framework for prioritizing variants in exome sequencing studies of Mendelian diseases , 2012, Nucleic acids research.

[28]  G. Driessen,et al.  Paediatric Reference Values for the Peripheral T cell Compartment , 2011, Scandinavian journal of immunology.

[29]  B. Wolska-Kuśnierz,et al.  B cell subsets in healthy children: Reference values for evaluation of B cell maturation process in peripheral blood , 2010, Cytometry. Part B, Clinical cytometry.

[30]  S. Hailfinger,et al.  Antigen receptor signaling to NF-kappaB via CARMA1, BCL10, and MALT1. , 2010, Cold Spring Harbor perspectives in biology.

[31]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[32]  Richard Durbin,et al.  Fast and accurate long-read alignment with Burrows–Wheeler transform , 2010, Bioinform..

[33]  Steven M. Holland,et al.  Primary Immunodeficiency Diseases: an Update on the Classification from the International Union of Immunological Societies Expert Committee for Primary Immunodeficiency 2015 , 2009, Front. Immun..

[34]  E. Johnston,et al.  Contaminants reduce the richness and evenness of marine communities: a review and meta-analysis. , 2009, Environmental pollution.

[35]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[36]  M. Thome.  Multifunctional roles for MALT1 in T-cell activation , 2008, Nature Reviews Immunology.

[37]  David J. Rawlings,et al.  Phosphorylation of the CARMA1 Linker Controls NF-κB Activation , 2005 .

[38]  R. Somech,et al.  Mutation analysis should be performed to rule out gammac deficiency in children with functional severe combined immune deficiency despite apparently normal immunologic tests. , 2005, The Journal of pediatrics.

[39]  C. Keylock.  Simpson diversity and the Shannon–Wiener index as special cases of a generalized entropy , 2005 .

[40]  M. Thome.  CARMA1, BCL-10 and MALT1 in lymphocyte development and activation , 2004, Nature Reviews Immunology.

[41]  V. Dixit,et al.  Regulation of NF-κB-Dependent Lymphocyte Activation and Development by Paracaspase , 2003, Science.

[42]  R. Gelman,et al.  Lymphocyte subsets in healthy children from birth through 18 years of age: the Pediatric AIDS Clinical Trials Group P1009 study. , 2003, The Journal of allergy and clinical immunology.

[43]  Jürgen Ruland,et al.  Differential requirement for Malt1 in T and B cell antigen receptor signaling. , 2003, Immunity.

[44]  M. Seto,et al.  Bcl10 and MALT1, Independent Targets of Chromosomal Translocation in MALT Lymphoma, Cooperate in a Novel NF-κB Signaling Pathway* , 2001, The Journal of Biological Chemistry.

[45]  M. Dyer,et al.  Bcl10 Is Involved in t(1;14)(p22;q32) of MALT B Cell Lymphoma and Mutated in Multiple Tumor Types , 1999, Cell.

[46]  P. Isaacson,et al.  Malignant lymphoma of mucosa‐associated lymphoid tissue. A distinctive type of B‐cell lymphoma , 1983, Cancer.

[47]  W. Grody,et al.  The Value of T-Cell Receptor &ggr; (TRG) Clonality Evaluation by Next-Generation Sequencing in Clinical Hematolymphoid Tissues: A Descriptive Study of 41 Cases From a Single Institution , 2018, American journal of clinical pathology.

[48]  V. Giudicelli,et al.  IMGT(®) tools for the nucleotide analysis of immunoglobulin (IG) and T cell receptor (TR) V-(D)-J repertoires, polymorphisms, and IG mutations: IMGT/V-QUEST and IMGT/HighV-QUEST for NGS. , 2012, Methods in molecular biology.

[49]  A. Bandaranayake,et al.  Phosphorylation of the CARMA1 linker controls NF-kappaB activation. , 2005, Immunity.

[50]  E. H. Simpson.  Measurement of Diversity , 1949, Nature.